What we promise?
Product | 4-Hydroxy Atorvastatin D5 Calcium Salt |
---|---|
CAT No. | CS-O-14019 |
CAS No. | 265989-45-5 |
Status | Available for Dispatch by 24-Sep-2023 |
Category | Stable Isotopes |
Mol. Wt. | 598.69 mol/g |
Mol. For. | C₃₃H₂₉FN₂O₆D₅.1/2Ca |
Hazardous |
![]() |
4-Hydroxy Atorvastatin D5 Calcium Salt is a pharmaceutical compound that is commonly used as a cholesterol-lowering medication. It is a calcium salt of the D5 isomer of the hydroxy form of Atorvastatin and is labeled with deuterium at the fifth position of the isopropyl group. Atorvastatin is a member of the statin class of drugs, which work by inhibiting the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol in the liver. This compound is used to reduce the levels of low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, which can lead to the development of heart disease. Additionally, it may be used to reduce the levels of triglycerides and increase the levels of high-density lipoprotein (HDL) cholesterol, which is commonly referred to as "good" cholesterol. In terms of its chemical structure, 4-Hydroxy Atorvastatin D5 Calcium Salt is a white, crystalline powder that is slightly soluble in water. Its molecular formula is C33H35D5CaF2N2O5, and it has a molecular weight of 736.9 g/mol. In conclusion, 4-Hydroxy Atorvastatin D5 Calcium Salt is a pharmaceutical compound that is used to lower cholesterol levels and prevent the development of heart disease. Its chemical structure is characterized by a white, crystalline powder that is slightly soluble in water, and it has a molecular weight of 736.9 g/mol.
Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
---|---|
Controlled | No |
Parent API | Atorvastatin |
Purity | Not less than 90% |
Therapeutic | Anti-Diabetic |
Isotopic Enrichment | Not less than 95% |
Smileys | O[C@@H](C[C@@H](O)CC(O)=O)CCN1C(C2=CC=C(F)C=C2)=C(C(C([2H])=C3[2H])=C(C([2H])=C3[2H])[2H])C(C(NC4=CC=C(O)C=C4)=O)=C1C(C)C.O[C@@H](C[C@@H](O)CC(O)=O)CCN5C(C6=CC=C(F)C=C6)=C(C(C([2H])=C7[2H])=C(C([2H])=C7[2H])[2H])C(C(NC8=CC=C(O)C=C8)=O)=C5C(C)C.[CaH2] |
Hazardous | Yes |
General Information | Use proper personal protective equipment |
---|---|
Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
Clothing | Wear appropriate protective clothing to minimize contact with skin. |
Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
Inhalation | Remove from exposure and move to fresh air immediately. |
![]() |
4-Hydroxy Atorvastat... | www.clearsynth.com |
CAT : CS-O-14019 | BATCH : CSC-WWW0757 |
|
MF: C₃₃H₂₉FN₂O₆D₅.1/2Ca CAS: 265989-45-5 Date of Anaysis: 19-Aug-2023 Retest Date: 19-Jun-2026 |
MW: 598.69
Store at refrigerator (2-8C) |
Qty: 60 MG |
Only for R & D and Analytical purpose, Not for Human Consumption. |
Impurities
Impurities
API Standards
API Standards
Impurities
Impurities
Impurities
Impurities
Intermediates
Metabolites
Impurities
Impurities
Impurities
Glucuronides
Impurities
Impurities
API Standards
EP Standards
API Standards
Secondary Standards
Impurities
Impurities
Impurities
Stable Isotopes
Stable Isotopes
Stable Isotopes
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Need a Quote?
Your email address will not be published. Required fields are marked *